asa glp 1 statement glp-1 A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia Glucagon-Like Peptide-1 Receptor Agonists in
Description
The similarities are not coincidental

During active weight loss, appetite may decrease, motivation may be high, and progress may be visible

, Akerstrom, V

With any successful, calorie restrictive diet there is a reduction of crucial nutrients which results is significant unintended effects on the body

However, the incidence of clinically meaningful muscle wasting under GLP-1RA therapy remains to be determined through prospective studies with standardized assessment methods

(5.5) Immunogenicity: Patients may develop antibodies to exenatide